{
    "code": "02025502",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025502",
    "time": "2023-04-21 03:34:31",
    "許可證字號": "衛署藥輸字第025502號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/08\/12",
    "發證日期": "100\/08\/12",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202550202",
    "中文品名": "格胰比瑞",
    "英文品名": "Glimepiride",
    "適應症": "非胰島素依賴型(第二型)糖尿病。",
    "劑型": "040（粉）",
    "包裝": "０．５公斤以上",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "620110J502  東譽興業股份有限公司",
    "申請商地址": "台北市中山區南京東路２段２０６號８樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIN0444400  HETERO DRUGS LTD. (Unit-I)",
            "製造廠廠址": "Sy. No.213, 214&amp; 255, Bonthapally Village, Gummadidala Mandal, Sangareddy District, Telangana state, India",
            "製造廠公司地址": "",
            "製造廠國別": "INDIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "Glimepiride 格胰比瑞-藥輸025502號___20110823.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025502&Seq=001&Type=9"
        },
        {
            "title": "Glimepiride-標籤-105-07-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025502&Seq=001&Type=8"
        }
    ]
}